|
BELLO C.-CEA M.-DAL BELLO G.-GARUTI A.-ROCCO I.-CIRMENA G.-MORAN
E.-NAHIMANA A.-DUCHOSAL M.-FRUSCIONE F.-PRONZATO P.-GROSSI F.-
PATRONE F.-BALLESTRERO A.-DUPUIS M.-SORDAT B.-NENCIONI A.-VOGEL P.
Novel 2/[(benzylamino)methyl]pyrrolidine/3,4/diol derivatives as
alpha/mannosidase inhibitors and with antitumor activities against
hematological and solid malignancies.
Bioorg. Med. Chem. 18:3320/3334, 2010
PubMed Abstract
BORCARD F.-BAUD M.-BELLO C.-DAL BELLO G.-GROSSI F.-PRONZATO P.-CEA
M.-NENCIONI A.-VOGEL P.
Synthesis of new oxathiazinane dioxides and their in vitro cancer
cell growth inhibitory activity.
Bioorg. Med. Chem. Lett. 20:5353/5356, 2010
PubMed Abstract
FAVONI R.E.-PATTAROZZI A.-LO CASTO M.-BARBIERI F.-GATTI M.-PALEARI
L.-BAJETTO A.-PORCILE C.-GAUDINO G.-MUTTI L.-CORTE G.-FLORIO T.
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to
inhibit pleural mesothelioma cell proliferation.
Curr. Cancer Drug Targets 10:176/191, 2010
PubMed Abstract
SCAGLIOTTI G.-NOVELLO S.-VON PAWEL J.-RECK M.-PEREIRA J.-THOMAS M.-
ABRAO MIZIARA J.-BALINT B.-DE MARINIS F.-KELLER A.-AREN O.-CSOLLAK
M.-ALBERT I.-BARRIOS C.-GROSSI F.-KRZAKOWSKI M.-CUPIT L.-CIHON F.-
DIMATTEO S.-HANNA N.
Phase III study of carboplatin and paclitaxel alone or with
sorafenib in advanced non small cell lung cancer.
J. Clin. Oncol. 28(11):1835/1842, 2010
PubMed Abstract
AIROLDI I.-DI CARLO E.-COCCO C.-CACI E.-CILLI M.-SORRENTINO C.-
SOZZI G.-FERRINI S.-ROSINI S.-BERTOLINI G.-TRUINI M.-GROSSI F.-
GALIETTA L.-RIBATTI D.-PISTOIA V.
IL/12 can target human lung adenocarcinoma cells and normal
bronchial epithelial cells surrounding tumor lesions.
PLoS One 4:e6119;1/e6119;11, 2009
PubMed Abstract
ALAMA A.-TASSO B.-NOVELLI F.-SPARATORE F.
Organometallic compounds in oncology: implications of novel
organotins as antitumor agents.
Drug. Discov. Today 14:500/508, 2009
PubMed Abstract
CESARIO A.-DALL'ARMI V.-CUSUMANO G.-FERRI L.-MARGARITORA S.-
CARDACI V.-CAFAROTTI S.-RUSSO P.-PALEARI L.-STERZI S.-PASQUA F.-
BONASSI St.-GRANONE P.
Post operative pulmonary rehabilitation after lung resection for
NSCLC: a follow up study. Letter.
Lung Cancer 66:268/269, 2009
PubMed Abstract
D'ANGELILLO R.-TRODELLA L.-CIRESA M.-CELLINI F.-FIORE M.-GRECO C.-
POMPEO E.-MINEO T.-PALEARI L.-GRANONE P.-RAMELLA S.-CESARIO A.
Multimodality treatment of stage III non small cell lung cancer.
Analysis of a phase II trial using preoperative cisplatin and
gemcitabine with concurrent radiotherapy.
J. Thorac. Oncol. 4:1517/1523, 2009
PubMed Abstract
DI VINCI A.-SESSA F.-CASCIANO I.-BANELLI B.-FRANZI F.-BRIGATI C.-
ALLEMANNI G.-RUSSO P.-DOMINIONI L.-ROMANI M.
Different intracellular compartmentalization of TA and DeltaNp73
in non small cell lung cancer.
Int. J. Oncol. 34:449/456, 2009
PubMed Abstract
GANGEMI R.-PALEARI L.-ORENGO A.M.-CESARIO A.-CHESSA L.-FERRINI S.-
RUSSO P.
Cancer stem cells: a new paradigm for understanding tumor growth
and progression and drug resistance.
Curr. Med. Chem. 16:1688/1703, 2009
PubMed Abstract
GROSSI F.-AITA M.-DEFFERRARI C.-ROSETTI F.-BRIANTI A.-FASOLA G.-
VINANTE O.-PRONZATO P.-PAPPAGALLO G.
Impact of third generation drugs on the activity of first line
chemotherapy in advanced non small cell lung cancer: a meta
analytical approach.
Oncologist 14:497/510, 2009
PubMed Abstract
PALEARI L.-ROTOLO N.-IMPERATORI A.-PUZONE R.-SESSA F.-FRANZI F.-
MEACCI E.-CAMPLESE P.-CESARIO A.-PAGANUZZI M.
Osteopontin is not a specific marker in malignant pleural
mesothelioma.
Int. J. Biol. Markers 24:112/117, 2009
PubMed Abstract
RAMELLA S.-TRODELLA L.-MINEO T.-POMPEO E.-STIMATO G.-GAUDINO D.-
VALENTINI V.-CELLINI F.-CIRESA M.-FIORE M.-PIERMATTEI A.-RUSSO P.-
CESARIO A.-D'ANGELILLO R.
Adding ipsilateral V(20) and V(30) to conventional dosimetric
constraints predicts radiation pneumonitis in stage IIIA/B NSCLC
treated with combined modality therapy.
Int. J. Radiat. Oncol. Biol. Phys. 76:110/115, 2010 - Epub Jul 18, 2009
PubMed Abstract
ROTONDO R.-BARISIONE G.-MASTRACCI L.-GROSSI F.-ORENGO A.M.-COSTA
R.-TRUINI M.-FABBI M.-FERRINI S.-BARBIERI O.
IL/8 induces exocytosis of arginase 1 by neutrophil
polymorphonuclears in nonsmall cell lung cancer.
Int. J. Cancer 125:887/893, 2009
PubMed Abstract
VIALE M.-CORDAZZO C.-DE TOTERO D.-BUDRIESI R.-ROSANO C.-LEONI A.-
IOAN P.-AIELLO C.-CROCE M.-ANDREANI A.-RAMBALDI M.-RUSSO P.-
CHIARINI A.-SPINELLI D.
Inhibition of MDR1 activity and induction of apoptosis by
analogues of nifedipine and diltiazem: an in vitro analysis.
Invest. New Drugs Epub Oct 30, 2009
PubMed Abstract
AITA M.-FASOLA G.-DEFFERRARI C.-BRIANTI A.-DAL BELLO M.G.-FOLLADOR
A.-SINACCIO G.-PRONZATO P.-GROSSI F.
Targeting the VEGF pathway: antiangiogenic strategies in the
treatment of non small cell lung cancer.
Crit. Rev. Oncol. Hematol. 68:183/196, 2008
PubMed Abstract
ALAMA A.-VIALE M.-CILLI M.-BRUZZO C.-NOVELLI F.-TASSO B.-SPARATORE
F.
In vitro cytotoxic activity of tri/n/butyltin(IV)lupinylsulfide
hydrogen fumarate (IST/FS 35) and preliminary antitumor activity
in vivo.
Invest. New Drugs 27:124/130, 2009 - Epub Jun 19, 2008
PubMed Abstract
BERTOLINI G.-PALEARI L.-CATASSI A.-ROZ L.-CESARIO A.-SOZZI G.-
RUSSO P.
In vivo cancer imaging with semiconductor quantum dots.
Curr. Pharm. Anal. 4:197/205, 2008
CERESOLI G.-CASTAGNETO B.-ZUCALI P.-FAVARETTO A.-MENCOBONI M.-
GROSSI F.-CORTINOVIS D.-DEL CONTE G.-CERIBELLI A.-BEARZ A.-
SALAMINA S.-DE VINCENZO F.-CAPPUZZO F.-MARANGOLO M.-TORRI V.-
SANTORO A.
Pemetrexed plus carboplatin in elderly patients with malignant
pleural mesothelioma: combined analysis of two phase II trials.
Br. J. Cancer 99:51/56, 2008
PubMed Abstract
DE MARINIS F.-GROSSI F.
Clinical evidence for second and third line treatment options in
advanced non small cell lung cancer.
Oncologist 13(suppl 1):14/20, 2008
PubMed Abstract
GRIDELLI C.-MAIONE P.-AMOROSO D.-BALDARI M.-BEARZ A.-BETTOLI V.-
CAMMILLUZZI E.-CRINO' L.-DE MARINIS F.-DI PIETRO F.-GROSSI F.-
INNOCENZI D.-MICALI G.-PIANTEDOSI F.-SCARTOZZI M.
Clinical significance and treatment of skin rash from erlotinib in
non small cell lung cancer patients: results of an Experts Panel
Meeting.
Crit. Rev. Oncol. Hematol. 66:155/162, 2008
PubMed Abstract
GROSSI F.-DE MARINIS F.-FRONTINI L.-GRIDELLI C.
Il dilemma della prima linea del carcinoma polmonare non a piccole
cellule in stadio avanzato: i farmaci di terza generazione sono
tutti uguali?
Tumori 94:5/14, 2008
PubMed Abstract
GROSSI F.-GRIDELLI C.-AITA M.-DE MARINIS F.
Identifying an optimum treatment strategy for patients with
advanced non small cell lung cancer.
Crit. Rev. Oncol. Hematol. 67:16/26, 2008
PubMed Abstract
ROTONDO R.-MASTRACCI L.-PIAZZA T.-BARISIONE G.-FABBI M.-CASSANELLO
M.-COSTA R.-MORANDI B.-ASTIGIANO S.-CESARIO A.-SORMANI M.-FERLAZZO
G.-GROSSI F.-RATTO G.B.-FERRINI S.-FRUMENTO G.
Arginase 2 is expressed by human lung cancer, but it neither
induces immune suppression, nor affects disease progression.
Int. J. Cancer 123:1108/1116, 2008
PubMed Abstract
RUSSO F.-BEARZ A.-PAMPALONI G.-Investigators Italian Pemetrexed
Monotherapy NSCLC Group-GROSSI F.
Pemetrexed single agent chemotherapy in previously treated
patients with locally advanced or metastatic non small cell lung
cancer.
BMC Cancer 8:216;1/216;7, 2008
PubMed Abstract
TISEO M.-ARDIZZONI A.-CAFFERATA M.-LOPREVITE M.-CHIARAMONDIA M.-FILIBERTI R.-MARRONI P.-GROSSI F.-PAGANUZZI M.
Predictive and prognostic significance of neuron specific enolase
(NSE) in non small cell lung cancer.
Anticancer Res. 28:507/514, 2008
PubMed Abstract
TISEO M.-GRIDELLI C.-CASCINU S.-CRINO' L.-PIANTEDOSI F.-GROSSI F.-
BRANDES A.-LABIANCA R.-SIENA S.-AMOROSO D.-BELVEDERE O.-VALENTINO
B.-BEARZ A.-VENTURINO P.-ARDIZZONI A.
An expanded access program of erlotinib (Tarceva) in patients with
advanced non small cell lung cancer (NSCLC): data report from
Italy.
Lung Cancer 64:199/206, 2009 - Epub Oct 23, 2008
PubMed Abstract
ALAMA A.-BARBIERI F.-SPAZIANTE R.-BRUZZO C.-DADATI P.-DORCARATTO A.-RAVETTI J.
Significance of cyclin D1 expression in meningiomas: a preliminary study.
J. Clin. Neurosci. 14:355/358, 2007
PubMed Abstract
CESARIO A.-FERRI L.-GALETTA D.-PASQUA F.-BONASSI S.-CLINI E.-BISCIONE G.-CARDACI V.-DI TORO S.-ZARZANA A.-MARGARITORA S.-
PIRAINO A.-RUSSO P.-STERZI S.-GRANONE P.
Post operative respiratory rehabilitation after lung resection for non small cell lung cancer.
Lung Cancer 57:175/180, 2007
PubMed Abstract
CESARIO A.-FERRI L.-GALETTA D.-CARDACI V.-BISCIONE G.-PASQUA F.-PIRAINO A.-BONASSI S.-RUSSO P.-STERZI S.-MARGARITORA S.-GRANONE P.
Pre operative pulmonary rehabilitation and surgery for lung cancer. Letter.
Lung Cancer 57:118/119, 2007
D'ANGELILLO R.-TRODELLA L.-RAMELLA S.-CELLINI N.-BALDUCCI M.-MANTINI G.-CELLINI
F.-CIRESA M.-FIORE M.-EVOLI A.-STERZI S.-RUSSO P.-GROZIO A.-CESARIO A.-GRANONE
P.
Novel prognostic groups in thymic epithelial tumors: assessment of risk
and therapeutic strategy selection.
Int. J. Radiat. Oncol. Biol. Phys. Epub Dec 28, 2007
PubMed Abstract
FASOLA G.-BELVEDERE O.-AITA M.-ZANIN T.-FOLLADOR A.-CASSETTI P.-MEDURI S.-DE
PANGHER V.-PIGNATA G.-ROSOLEN V.-BARBONE F.-GROSSI F.
Low dose computed tomography screening for lung cancer and pleural
mesothelioma in an asbestos exposed population: baseline results of a
prospective, nonrandomized feasibility trial. An Alpe Adria Thoracic Oncology
Multidisciplinary Group Study (ATOM 002).
Oncologist 12:1215/1224, 2007
PubMed Abstract
GRIDELLI C.-FERRARA C.-GUERRIERO C.-PALAZZO S.-GRASSO G.-PAVESE I.-SATTA F.-BAJETTA E.-CORTINOVIS D.-BARBIERI F.-GEBBIA V.-GROSSI F.-
NOVELLO S.-BALDINI E.-GASPARINI G.-LATINO W.-DURANTE E.-GIUSTINI L.-NEGRINI C.
Informal caregiving burden in advanced non small cell lung cancer: the HABIT study.
J. Thorac. Oncol. 2:475/480, 2007
PubMed Abstract
GROSSI F.-AITA M.
Bevacizumab and non small cell lung cancer: starving the enemy to survive.
Expert Opin. Biol. Ther. 7:1107/1119, 2007
PubMed Abstract
GROSSI F.-AITA M.-FOLLADOR A.-DEFFERRARI C.-BRIANTI A.-SINACCIO G.-BELVEDERE O.
Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non small cell lung cancer: a review of
the literature.
Oncologist 12:451/464, 2007
PubMed Abstract
GROSSI F.-DE MARINIS F.
Il percorso terapeutico nei pazienti con tumore polmonare non a piccole cellule in stadio avanzato.
Tumori 93:1/15, 2007
PubMed Abstract
GROZIO A.-CATASSI A.-CAVALIERI Z.-PALEARI L.-CESARIO A.-RUSSO
P.
Nicotine, lung and cancer.
Anticancer Agents Med. Chem. 7:461/466, 2007
PubMed Abstract
LOPREVITE M.-TISEO M.-CHIARAMONDIA M.-CAPELLETTI M.-BOZZETTI C.-BORTESI B.-NALDI
N.-NIZZOLI R.-DADATI P.-KUNKL A.-ZENNARO D.- LAGRASTA C.-CAMPANINI N.-SPIRITELLI
E.-CAMISA R.-GROSSI F.-RINDI G.-FRANCIOSI V.-ARDIZZONI A.
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in
patients with advanced non small cell lung cancer.
Clin. Cancer Res. 13:6518/6526, 2007
PubMed Abstract
PALEARI L.-GRANONE P.-GROZIO A.-CESARIO A.-RUSSO P.
Commentary: early diagnosis of lung cancer: where do we stand?
Oncologist 12:1433/1436, 2007
PALEARI L.-GROZIO A.-CESARIO A.-RUSSO P.
The cholinergic system and cancer.
Semin. Cancer Biol. 18:211/217, 2008 - Epub Dec 23, 2007
PubMed Abstract
PALEARI L.-RUSSO P.-CESARIO A.-GRANONE P.
Inflammation and thoracic surgery: a complex interaction. Letter.
Eur. J. Cardiothorac. Surg. 32:950, 2007
PubMed Abstract
ARDIZZONI A.-CAFFERATA M.-TISEO M.-FILIBERTI R.-MARRONI P.-GROSSI F.-PAGANUZZI M.
Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
Cancer 107:2842/2849, 2006
PubMed Abstract
BELVEDERE O.-GROSSI F.
Lung cancer highlights from ASCO 2005.
Oncologist 11:39/50, 2006
PubMed Abstract
CERESOLI G.-ZUCALI P.-FAVARETTO A.-GROSSI F.-BIDOLI P.-DEL CONTE G.-CERIBELLI A.-BEARZ A.-MORENGHI E.-CAVINA R.-MARANGOLO M.-
SOTO H.-SANTORO A.
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.
J. Clin. Oncol. 24:1443/1448, 2006
PubMed Abstract
GALETTA D.-CESARIO A.-MARGARITORA S.-PORZIELLA V.-PIRAINO A.-D'ANGELILLO R.-GAMBACORTA M.-RAMELLA S.-
TRODELLA L.-VALENTE S.-CORBO G.-MACIS G.-MULE' A.-CARDACI V.-STERZI S.-GRANONE P.-RUSSO P.
Multimodality treatment of unresectable stage III non small cell lung cancer: interim analysis of a phase II trial with
preoperative gemcitabine and concurrent radiotherapy.
J. Thorac. Cardiovasc. Surg. 131:314/321, 2006
PubMed Abstract
GROSSI F.-FASOLA G.-ROSSETTO C.-SPIZZO R.-MEDURI S.-SIBAU A.-VIGEVANI E.-TUMOLO S.-ADAMI G.-SACCO C.-
RECCHIA L.-RIZZATO S.-CESCHIA T.-BELVEDERE O.
Phase II study of irinotecan and docetaxel in patients with previously treated non small cell lung cancer: an Alpe Adria
Thoracic Oncology Multidisciplinary group study (ATOM 007).
Lung Cancer 52:89/92, 2006
PubMed Abstract
GROSSI F.-TISEO M.
Granulocyte growth factors in the treatment of non small cell lung cancer (NSCLC).
Crit. Rev. Oncol. Hematol. 58:221/230, 2006
PubMed Abstract
NERI M.-CESARIO A.-GRANONE P.-DOMINIONI L.-PUNTONI R.-D'ANGELILLO R.-RUSSO P.
Prognostic role of K/Ras mutations in non small cell lung cancer: still an issue for open debate. Letter.
Lung Cancer 53:393/395, 2006
PubMed Abstract
RINALDI M.-BELVEDERE O.-CAUCHI C.-DEFFERRARI C.-VIOLA G.-GROSSI F.
Maintenance chemotherapy in non small cell lung cancer.
Ann. Oncol. 17(suppl):ii67/ii70, 2006
PubMed Abstract
RUSSO P.-CATASSI A.-CESARIO A.-SERVENT D.
Development of novel therapeutic strategies for lung cancer: targeting the cholinergic system.
Curr. Med. Chem. 13:3493/3512, 2006
PubMed Abstract
TISEO M.-FRANCIOSI V.-GROSSI F.-ARDIZZONI A.
Adjuvant chemotherapy for non small cell lung cancer: ready for clinical practice?
Eur. J. Cancer 42:8/16, 2006
PubMed Abstract
TRODELLA L.-DE MARINIS F.-D'ANGELILLO R.-RAMELLA S.-CESARIO A.-VALENTE S.-NELLI F.-MIGLIORINO M.-MARGARITORA S.-CORBO G.-PORZIELLA V.-CIRESA M.-CELLINI F.-BONASSI S.-RUSSO P.-CORTESI E.-GRANONE P.
Induction cisplatin/gemcitabine/paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non small cell lung cancer.
Lung Cancer 54:331/338, 2006
PubMed Abstract
Per le pubblicazioni 2000-2005 del personale della struttura vedere gli
elenchi generali.
|
Presentazione della struttura